Publications by authors named "Amanda R Moore"

Claim this Profile
E
ETV4 mediates dosage-dependent prostate tumor initiation and cooperates with p53 loss to generate prostate cancer.
Dan Li, Yu Zhan, Naitao Wang, Fanying Tang, Cindy J Lee, Amanda R Moore

Sci Adv· April 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Direct evidence that the GPCR CysLTR2 mutant causative of uveal melanoma is constitutively active with highly biased signaling.
Emilie Ceraudo, Mizuho Horioka, Jordan M Mattheisen, Tyler D Hitchman, Amanda R Moore

J Biol Chem· August 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The promise and peril of KRAS G12C inhibitors.
Amanda R Moore, Shiva Malek

Cancer Cell· August 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
ARAF mutations confer resistance to the RAF inhibitor belvarafenib in melanoma.
Ivana Yen, Frances Shanahan, Jeeyun Lee, Yong Sang Hong, Sang Joon Shin, Amanda R Moore

Nature· June 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
RAS-targeted therapies.
Amanda R Moore, Scott C Rosenberg, Frank McCormick, Shiva Malek

Nat Rev Drug Discov· May 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Combined Inhibition of Gα and MEK Enhances Therapeutic Efficacy in Uveal Melanoma.
Tyler D Hitchman, Gabriella Bayshtok, Emilie Ceraudo, Amanda R Moore, Cindy Lee

Clin Cancer Res· March 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Author Correction: RAS-targeted therapies: is the undruggable drugged?
Amanda R Moore, Scott C Rosenberg, Frank McCormick, Shiva Malek

Nat Rev Drug Discov· December 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
G
GNA11 Q209L Mouse Model Reveals RasGRP3 as an Essential Signaling Node in Uveal Melanoma.
Amanda R Moore, Leili Ran, Youxin Guan, Jessica J Sher, Tyler D Hitchman

Cell Rep· October 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
RAS-targeted therapies: is the undruggable drugged?
Amanda R Moore, Scott C Rosenberg, Frank McCormick, Shiva Malek

Nat Rev Drug Discov· August 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Spliceosomal disruption of the non-canonical BAF complex in cancer.
Daichi Inoue, Guo-Liang Chew, Bo Liu, Brittany C Michel, Joseph Pangallo, Amanda R Moore

Nature· October 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
G
GNA11 Q209L Mouse Model Reveals RasGRP3 as an Essential Signaling Node in Uveal Melanoma.
Amanda R Moore, Leili Ran, Youxin Guan, Jessica J Sher, Tyler D Hitchman

Cell Rep· February 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A Tmprss2-CreERT2 Knock-In Mouse Model for Cancer Genetic Studies on Prostate and Colon.
Dong Gao, Yu Zhan, Wei Di, Amanda R Moore, Jessica J Sher

PLoS One· July 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Recurrent activating mutations of G-protein-coupled receptor CYSLTR2 in uveal melanoma.
Amanda R Moore, Emilie Ceraudo, Jessica J Sher, Youxin Guan, Alexander N Shoushtari

Nat Genet· June 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis